Paul Smith, President and COO of Orasis Pharmaceuticals, discusses Qlosi in this interview with Presbyopia Physician co-editors Dr. Jacob R. Lang and Dr. Jennifer Loh. Listen to Mr. Smith’s responses on how Qlosi got its name, the challenges faced by Orasis in bringing Qlosi to market, and more.
Clip #1 - How Qlosi was named
Clip #2 - Challenges faced in bringing Qlosi to market
Clip #3 - The team at Orasis
Clip #4 - What makes Qlosi unique
![]({"src":"/media/lvteveez/june-pp-cover.jpg","focalPoint":null,"crops":[{"alias":"thumbnail","width":1110,"height":700,"coordinates":null}]})